Basics of managing breakthrough cancer pain

Pharmaceutical Journal

Volumn 283, Issue 7566-7567, 2009, Pages 213-216

  Dickman, Andrew ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955897965     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Foley KM. Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Cherny N, Caiman K, editors. Oxford textbook of palliative medicine. 3rd ed. Oxford University Press. Oxford; 2004
2. Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006(1):CD004311
3. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. European Journal of Pain 2009;13:331-8.
4. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999; 82:263-74.
5. Abernethy AP, Wheeler JL, Fortner BV. A health economic model of breakthrough pain. American Journal of Managed Care 2008; 14:S129-40.
6. WHO cancer pain relief. Geneva: WHO; 1986.
7. Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. British Journal of Cancer 2001;84:587-93.
8. Mystakidou K, Katsouda E, Parpa E, Tsiatas ML, Vlahos L. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. Americal Journal of Hospice and Palliative Care 2005; 22:228-32.
9. Slatkin NE, XJe F, Messina J, Segal TJ. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. The Journal of Supportive Oncology 2007;5:327-34.